SCHEMBL24200436

SCHEMBL24200436

Cn1c2ccccc2c2cc(C(=O)O)nc(-c3ccccc3C=O)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
AHR P35869 1/20 0.39
HDAC3 O15379 4/20 0.38
HDAC4 P56524 4/20 0.38
HDAC1 Q13547 4/20 0.38
HDAC7 Q8WUI4 4/20 0.38
HDAC2 Q92769 4/20 0.38
HDAC10 Q969S8 4/20 0.38
HDAC11 Q96DB2 4/20 0.38
HDAC8 Q9BY41 4/20 0.38
HDAC6 Q9UBN7 4/20 0.38
HDAC9 Q9UKV0 4/20 0.38
HDAC5 Q9UQL6 4/20 0.38
HPGD P15428 3/20 0.37
HSD17B10 Q99714 3/20 0.37
ALDH1A1 P00352 4/20 0.36
LMNA P02545 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
IMPDH2 P12268 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20147219 0.83 AHR (0.42) KDM4EAHRHDAC3HDAC4HDAC1
SCHEMBL2214815 0.82 KDM4E (0.47) KDM4EHDAC3HDAC4HDAC1HDAC7
SCHEMBL27962902 0.77 HDAC3 (0.47) KDM4EHDAC3HDAC4HDAC1HDAC7
SCHEMBL27962882 0.77 PTGER1 (0.48) KDM4EHDAC3HDAC4HDAC1HDAC7
SCHEMBL2218077 0.76 KDM4E (0.49) KDM4EHPGDHSD17B10ALDH1A1LMNA
SCHEMBL24200425 0.76 ALKBH5 (0.41) KDM4EAHRHPGDHSD17B10ALDH1A1
SCHEMBL27962930 0.74 ALDH1A1 (0.56) KDM4EHPGDHSD17B10ALDH1A1LMNA
SCHEMBL29217020 0.73 KDM4E (0.46) KDM4EHPGDHSD17B10ALDH1A1LMNA
SCHEMBL25411401 0.73 MAPT (0.49) KDM4EHDAC3HDAC4HDAC1HDAC7
SCHEMBL2214686 0.72 KDM4E (0.45) KDM4EHPGDHSD17B10ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538529-B1 SELECTIVE INHIBITORS OF GENOTOXIC STRESS-INDUCED IKK/NF-KB PATHWAYS MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT (DE) 2022-01-19 EP disclosed